Page 207 - Remedial Andrology

760. Mirone, V., et al. Results from a prospective observational study of men with premature ejaculation
treated with dapoxetine or alternative care: the PAUSE study. Eur Urol, 2014. 65: 733.
https://pubmed.ncbi.nlm.nih.gov/23993257
761. Dresser, M.J., et al. Dapoxetine, a novel treatment for premature ejaculation, does not have
pharmacokinetic interactions with phosphodiesterase-5 inhibitors. Int J Impot Res, 2006. 18: 104.
https://pubmed.ncbi.nlm.nih.gov/16307008
762. McMahon, C.G., et al. Efficacy and safety of dapoxetine in men with premature ejaculation and
concomitant erectile dysfunction treated with a phosphodiesterase type 5 inhibitor: randomized,
placebo-controlled, phase III study. J Sex Med, 2013. 10: 2312.
https://pubmed.ncbi.nlm.nih.gov/23845016
763. Abu El-Hamd, M., et al. Comparison of the clinical efficacy and safety of the on-demand use of
paroxetine, dapoxetine, sildenafil and combined dapoxetine with sildenafil in treatment of patients
with premature ejaculation: A randomised placebo-controlled clinical trial. Andrologia, 2018. 50.
https://pubmed.ncbi.nlm.nih.gov/28497478
764. Tuken, M., et al. Efficacy and safety of dapoxetine/sildenafil combination tablets in the treatment
of men with premature ejaculation and concomitant erectile dysfunction-DAP-SPEED Study. Int J
Impot Res, 2019. 31: 92.
https://pubmed.ncbi.nlm.nih.gov/30705437
765. Park, H.J., et al. Discontinuation of Dapoxetine Treatment in Patients With Premature Ejaculation: A
2-Year Prospective Observational Study. Sex Med, 2017. 5: e99.
https://pubmed.ncbi.nlm.nih.gov/28395997
766. Jern, P., et al. Antidepressant treatment of premature ejaculation: discontinuation rates and
prevalence of side effects for dapoxetine and paroxetine in a naturalistic setting. Int J Impot Res,
2015. 27: 75.
https://pubmed.ncbi.nlm.nih.gov/25410962
767. Peng, J., et al. Efficacy of dapoxetine treatment in Chinese patients with premature ejaculation and
possible factors affecting efficacy in the real-world practice. BMC Urol, 2020. 20: 11.
https://pubmed.ncbi.nlm.nih.gov/32013958
768. Borgdorff, A.J., et al. Ejaculation elicited by microstimulation of lumbar spinothalamic neurons. Eur
Urol, 2008. 54: 449.
https://pubmed.ncbi.nlm.nih.gov/18394782
769. Truitt, W.A., et al. Identification of a potential ejaculation generator in the spinal cord. Science, 2002.
297: 1566.
https://pubmed.ncbi.nlm.nih.gov/12202834
770. Giuliano, F. 5-Hydroxytryptamine in premature ejaculation: opportunities for therapeutic intervention.
Trends Neurosci, 2007. 30: 79.
https://pubmed.ncbi.nlm.nih.gov/17169440
771. Waldinger, M.D., et al. Paroxetine treatment of premature ejaculation: a double-blind, randomized,
placebo-controlled study. Am J Psychiatry, 1994. 151: 1377.
https://pubmed.ncbi.nlm.nih.gov/8067497
772. Olivier, B., et al. Serotonin, serotonergic receptors, selective serotonin reuptake inhibitors and sexual
behaviour. Int Clin Psychopharmacol, 1998. 13 Suppl 6: S9.
https://pubmed.ncbi.nlm.nih.gov/9728669
773. Zhang, D., et al. Paroxetine in the treatment of premature ejaculation: a systematic review and meta-
analysis. BMC Urol, 2019. 19: 2.
https://pubmed.ncbi.nlm.nih.gov/30606186
774. Waldinger, M.D. Emerging drugs for premature ejaculation. Expert Opin Emerg Drugs, 2006. 11: 99.
https://pubmed.ncbi.nlm.nih.gov/16503829
775. Waldinger, M.D. Premature ejaculation: definition and drug treatment. Drugs, 2007. 67: 547.
https://pubmed.ncbi.nlm.nih.gov/17352514
776. Goodman, R.E. An assessment of clomipramine (Anafranil) in the treatment of premature
ejaculation. J Int Med Res, 1980. 8 Suppl 3: 53.
https://pubmed.ncbi.nlm.nih.gov/7193614
777. Choi, J.B., et al. Efficacy and Safety of On Demand Clomipramine for the Treatment of Premature
Ejaculation: A Multicenter, Randomized, Double-Blind, Phase III Clinical Trial. J Urol, 2019. 201: 147.
https://pubmed.ncbi.nlm.nih.gov/30086277
778. Kim, S.W., et al. Tolerability and adequate therapeutic dosage of oral clomipramine for the treatment
of premature ejaculation: A randomized, double-blind, placebo-controlled, fixed-dose, parallel-
grouped clinical study. Int J Impot Res, 2018. 30: 65.
https://pubmed.ncbi.nlm.nih.gov/29203842

206 SEXUAL AND REPRODUCTIVE HEALTH - MARCH 2021